Prospective randomized trial of two different immunoadsorbers in severe systemic lupus erythematosus

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 495-501

  Gaubitz, Markus ^a,c   Seidel, Matthias ^a   Kummer, Sascha ^a   Schotte, Heiko ^a   Perniok, Andreas ^b   Domschke, Wolfram ^a   Schneider, Matthias ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Medical Clinic B   (Germany)

Author keywords

Extracorporeal treatment; Immunoadsorption; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA ANTIBODY; IMMUNOGLOBULIN; LIGAND; PHENYLALANINE;

ADULT; ANTIGEN ANTIBODY COMPLEX; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOADSORBENT; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032192571     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0229     Document Type: Conference Paper

References (23)

1. 1. Koffler D., Agnello V., Thoburn R., Kunkel H.G. 1971. Systemic lupus erythematosus: prototype of immune complex nephritis in man. J. Exp. Med. 134: 169s-179s
2. 2. Mannik M. 1982. Pathophysiology of circulating immune complexes. Arthritis Rheum. 27: 783-787
3. 3. Jones J.V., Cumming R.H., Bucknall R.C., Asplin C.M. 1976. Plasmapheresis in the management of acute systemic lupus erythematosus? Lancet 1: 711-715
4. 4. Lockwood C.M., Pussel B., Wilson C.B., Peters D.K. 1979. Plasma exchange in Nephritis. Adv. Nephrol. 8: 383-418
5. 5. Leaker B.R., Becker G.J., Dowling J.P., Kincaid-Smith P.S. 1986. Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression. Clin. Nephrol. 25: 236-244
6. 6. Wei N., Klippel J.H., Huston D.P, Hall R.P., Lawley T.J., Balow J.E., Steinberg A.D., Decker J.L. 1983. Randomized trial of plasma exchange in mild systemic lupus erythematosus. Lancet 1: 17-22
7. 7. French Cooperative Study Group. 1985. A randomized trial of plasma exchange in severe acute lupus erythematosus: methodology and interim analysis. Plasma Ther. Trans. Tech. 6: 535-539
8. 8. Euler H.H., Schröder J.O., Harten P., Zeuner R.A., Gutschmidt H.J. 1994. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum. 37: 1784-1794
9. 9. Schneider M., Gaubitz M., Perniok A. 1997. Immunoadsorption in systemic connective tissue diseases and primary vasculitis. Ther. Apheresis 2: 117-120
10. 10. Hashimoto H., Tsuda H., Kanai Y., Kobayashi S., Hirose S., Shinoura H., Yokahari R., Kinoshita M., Aotsuka S., Yamada H., Takahashi K, Yoshinoya S., Miyamoto T. 1990. Selective removal of anti-DNA and anticardiolipin antibodies by adsorbent plasmapheresis using dextran sulfate columns in patients with systemic lupus erythematosus. J. Rheumatol. 18: 545-551
11. 11. Palmer A., Cairns T., Dische F., Gluck G., Gjorstrup P., Parons V., Welsh K., Taube D. 1991. Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide. Nephrol. Dial. Transplant. 6: 536-542
12. 12. Schneider M., Berning T., Waldendorf M., Glaser J., Gerlach U. 1990. Immunoadsorbent plasma perfusion in patients with systemic lupus erythematosus. J. Rheumatol. 17: 900-907
13. 13. Du Moulin A., Müller-Dehrlich J., Bieber F., Richter W.O., Frei U., Müller R., Spaethe R. 1993. Antibody-based immunoadsorption as a therapeutic means. Blood Purif. 11: 145-149
14. 14. Liang M.H., Socher S.A., Larsen M.G., Schur P.H. 1989. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 32: 1107-1108
15. 15. Barr W.G., Hubbell E.A., Robinson J.A. 1987. Persistently active systemic lupus erythematosus treated with intermittent plasmapheresis and bolus cyclophosphamide. In Proceedings of the first international conference of the World Apheresis Association: therapeutic plasmapheresis VI. T. Oda, Y. Shiokawa, N. Inoue, eds. Isaho Press, Cleveland, pp. 696-700
16. 16. Sharon Z., Roberts J.L., Fennel J.S., Schwartz M.M., Lewis E.J. 1982. Plasmapheresis in lupus nephritis. Plasma Ther. Transfus. Technol. 3: 163-169
17. 17. Lewis E.J., Hunsicker L.G., Lan S.P., Rohde R.D., Lachin J.M. 1992. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N. Engl. J. Med. 326: 1373-1379
18. 18. Schneider M. 1996. Plasma-und Lymphapherese bei Autoimmunopathien. Z. Rheumatol. 55: 90-104
19. 19. Lockwood C.M., Worledge S., Nicholas A., Cotton C., Peters D.K. 1979. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N. Engl. J. Med. 300: 524-530
20. 20. Horsfall A.C., Isenberg D.A. 1988. Idiotypes and autoimmunity: a review of their role in human disease. J. Autoimmunity 1: 17-30
21. 21. Suzuki K., Taman J., Matsuki Y., Hidaka T., Ishizuka T., Kawakami M., Yabuki T., Kutsuki H., Nakamura H. 1996. Anti-dsDNA antibody kinetics during in vivo apheresis in systemic lupus erythematosus patients and in an in vitro apheresis model. J. Clin. Apheresis 11: 211-216
22. 22. Euler H.H., Schroeder J.O. 1992. Antibody depletion and cytotoxic drug therapy in severe systemic lupus erythematosus. Transfus. Sci. 13: 167-184
23. 23. Aringer M., Smolen J.S., Graninger W.B. 1998. Severe infections in plasmapheresis-treated systemic lupus erythematosus. Arthritis Rheum. 41: 414-420